Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Archive

Hadassah Medical Center: One of Eight ASHA Grantees in the Middle East

Through the United States Agency for International Development's American Schools and Hospitals Abroad (ASHA) program, the Hadassah Medical Center—one of eight grantees in the Middle East--received over one million dollars in Fiscal Year 2012 to upgrade its surgical equipment.

ASHA's 2012 Annual Report notes: "ASHA has empowered Hadassah to incorporate the most effective advancements in surgery and technology to continue to be a model of American medical practices in the Middle East." This funding, it continues, "has provided an upgrade in surgical tools and medical equipment," including "surgical lamps, surgical tables, anesthesia systems and monitors, mobile x-ray systems, and laser surgery equipment."

In the over half century of its existence, the ASHA grant program has assisted 257 institutions in more than 75 countries. In FY 2012, ASHA awarded more than $20.5 million in grants and cooperative agreements, with about 38 percent—$7,900,000--going to the Middle East.

The eight Middle East ASHA grantees for Fiscal Year 2012 are:

  • American University of Beirut, Lebanon--$1,800,000
  • Hadassah Medical Center, Jerusalem, Israel--$1,300,000
  • Weizmann Institute of Science Feinberg Graduate School, Rehovot, Israel— $1,000,000
  • Lebanese American University, Beirut--$900,00
  • Ramallah Friends School, West Bank--$900,000
  • American University, Cairo, Egypt--$800,000
  • Shaare Zedek Medical Center, Jerusalem--$700,000
  • American Community School, Beirut--$500,000.
Date: 3/6/2013

More hMedicine Stories

Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America